PLAUR and familial pancreatic carcinoma: Yang et al24 reported that the systemic delivery of urokinase‐type plasminogen activator receptor (uPAR)‐targeted SPIO resulted in selective accumulation within tumours of an orthotopic human pancreatic cancer xenograft model in nude mice.